Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(28 sites)

United States

Associated Retina Consultants, Gilbert, Arizona

Associated Retina Consultants, Phoenix, Arizona

Doheny Image Reading Center, Pasadena, California

Bay Area Retina Associates, Walnut Creek, California

Retina Consultants of Southern Colorado, Colorado Springs, Colorado

Retina Group of New England, Waterford, Connecticut

Florida Retina Institute, Orlando, Florida

Retina Associates, Ltd., Elmhurst, Illinois

Retina Partners Midwest, P.C., Carmel, Indiana

Retina Research Institute at New England Retina Consultants, Springfield, Massachusetts

Associated Retinal Consultants, P.C., Royal Oak, Michigan

The Retina Institute, St Louis, Missouri

Sierra Eye Associates, Reno, Nevada

Retina Associates of Western NY, Rochester, New York

Long Island Vitreoretinal Consultants, Westbury, New York

North Carolina Retina Associates, S.C., Wake Forest, North Carolina

Erie Retina Research, LLC (Clinic), Erie, Pennsylvania

Charleston Neuroscience Institute, Mt. Pleasant, South Carolina

Palmetto Retina Center, West Columbia, South Carolina

Retina Consultants of Texas, Beaumont, Texas

Retina Consultants of Texas, Bellaire, Texas

Retina Consultants of Texas, Katy, Texas

Retina Associates of South Texas, PA, San Antonio, Texas

Retina Consultants of Texas, San Antonio, Texas

Retina Consultants of Texas, The Woodlands, Texas

Pacific Northwest Retina, Bellevue, Washington

Pacific Northwest Retina, PLLC, Silverdale, Washington

Canada

Clinique d'ophtalmologie des Laurentides, Boisbriand, Quebec